Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-03

Clinical Trial Update: Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether vitamin D3 (cholecalciferol) and omega-3 fatty acid supplementation can prevent type 2 diabetes has completed, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)
  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2026-04-03